dry eye disease
Nordic Pharma’s Lacrifill canalicular gel gains CE mark approval and set for European launch
April 14, 2025Market Access, Research and Development, Sales and Marketing Nordic Pharma, Opthalmology, dry eye disease
International pharma company Nordic Pharma has announced that its Lacrifill treatment for dry eye disease has received European Conformity (CE) …
All eyes on dry eye disease
May 8, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing TopiVert, dry eye disease, eye, pharma
Dr Matthew Fyfe, Head of Chemistry and Intellectual Property at TopiVert, gives an illuminating look into the latest developments in …
FDA to decide on Shire blockbuster hopeful
February 8, 2016Manufacturing and Production, Research and Development, Sales and Marketing Shire, dry eye disease, lifitegrast
The FDA has accepted Shire’s new drug application (NDA) for its dry eye disease drug lifitegrast, putting the treatment on …
Shire tries again with lifitegrast dry eye FDA application
January 25, 2016Manufacturing and Production, Sales and Marketing FDA, Shire, dry eye disease, lifitegrast
Shire has resubmitted its New Drug Application (NDA) to the US FDA for its rejected dry eye syndrome drug lifitegrast. …
New treatments to boost dry eye drug market – if approved
November 5, 2015Sales and Marketing Allergan, Ikervis, Restasis, Shire, cyclosporine, dry eye disease, dry eye syndrome, lifitegrast
The global market for treatments for dry eye syndrome will double in value to an estimated $4.6 billion by 2024, …
Featured market report: Summary of dry eye syndrome
November 5, 2015dry eye disease, dry eye syndrome, lifitegrast
This report provides the current prevalent population for dry eye syndrome across seven major markets.It includes data for the USA, …
New Phase III data puts Shire’s lifitegrast back on track for 2016 launch
October 27, 2015Research and Development Shire, dry eye disease, lifitegrast
Shire shares rose 6% today as the company reported new positive Phase III trial data for lifitegrast in the treatment …
Shire’s dry eye treatment gets a no – for now
October 19, 2015Sales and Marketing Complete Response Letter, FDA, Flemming Ornskov, Shire, dry eye disease, lifitegrast
Shire has seen an application for its dry eye treatment lifitegrast rejected by the US regulator. The FDA says it …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
